From these results it can be concluded that the use of dermal application of SNP “pad”, that increased insulin synthesis in the liver even when the pancreatic β cells are non-functioning, could possibly be an alternative modality for the control of hyperglycemia in T1DM without using external insulin, and, therefore could be therapeutically useful in this condition. This evidence concerns the gene INS and Hyperglycemia.